Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression.

BACKGROUND: Geriatric depression with subjective cognitive complaints increases the risk of Alzheimer’s Disease (AD). Memantine is a cognitive enhancer used to treat AD. In a 6-month double-blind randomized placebo-controlled trial of escitalopram and memantine (ESC/MEM), ESC/MEM improved cognition...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Affect Disord
Main Authors: Krause-Sorio, Beatrix, Siddarth, Prabha, Kilpatrick, Lisa, Laird, Kelsey T., Milillo, Michaela M., Ercoli, Linda, Narr, Katherine L., Lavretsky, Helen
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368564/
https://ncbi.nlm.nih.gov/pubmed/32663977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jad.2020.05.092
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados